# VANDA PHARMACEUTICALS INC (VNDA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/VNDA/

- Reporting holders: 4
- Reported value: $59.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $24.6K | 5,000 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $12.8K | 2,608 | 0.0% | 16 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $12.1K | 2,474 | 0.0% | 4 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $9.9K | 2,008 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $59.4K |
| Q2 2026 | 174 | $338.9M |
| Q1 2026 | 171 | $327.7M |
| Q4 2025 | 156 | $381.7M |
| Q3 2025 | 147 | $228.4M |
| Q2 2025 | 138 | $218.9M |
| Q1 2025 | 148 | $206.3M |
| Q4 2024 | 146 | $207.6M |
| Q3 2024 | 152 | $208.9M |
| Q2 2024 | 150 | $259.0M |
| Q1 2024 | 143 | $213.6M |
| Q4 2023 | 157 | $227.7M |